Company: MVIS
Filing Date: 2025-05-12
Form Type: 10-Q
Source: 0001641172-25-009765
Chunk: 197

Company: MICROVISION, INC.
Filing Date: 2025-05-12
Form: 10-Q
Item: Part I, Item 8
Chunk 197
---
 not designated as hedging instruments are as follows:

 SCHEDULE OF UNREALIZED GAIN AND LOSS INSTRUMENTS

    March
    31,  
    March
    31, 
  
    (in
    thousands) 
    2025  
    2024 
  
    Unrealized
    gain on derivative liability 
    $842  
    $- 
  
    Total 
    $842  
    $- 

Fair
Value Measurements

The
fair value of the derivative liability is determined utilizing a “with and without” method, in which the fair value is calculated
as the difference in the fair value of the entire hybrid instrument and the fair value of the instrument excluding the bifurcated derivative
features.

The
valuation inputs hierarchy classification for liabilities measured at fair value on a recurring basis are summarized below as of March
31, 2025 and December 31, 2024 (in thousands). See Note 5. Investment Securities, Available-For-Sale and Fair Value Measurements,
for discussion of the fair value level hierarchy.

 SCHEDULE
OF HIERARCHY LIABILITIES FAIR VALUE

    As of
    March 31, 2025 
    Level
    1  
    Level
    2  
    Level
    3 
  
    Derivative
    liability 
    $      -  
    $      -  
    $4,867 
  
    Total 
    $-  
    $-  
    $4,867 

    As of
    December 31, 2024 
    Level
    1  
    Level
    2  
    Level
    3 
  
    Derivative
    liability 
    $      -  
    $      -  
    $14,581 
  
    Total 
    $-  
    $-  
    $14,581 

The
table below lists the inputs and assumptions for the Company’s valuations as of March 31, 2025 and December 31, 2024:

 SCHEDULE
OF REVALUATION DERIVATIVE LIABILITY

    March
    31,  
    December
    31, 

    2025  
    2024 
  
    Expected term
    (years) 
     1.5  
     1.